The rhesus cytomegalovirus (RhCMV) strain 68-1 vaccine against simian immunodeficiency virus (SIV) induces a T cell response that protects over 50% of vaccinated rhesus macaques (RM) to clear infection against multiple SIV challenge including distinct challenge routes. To define the molecular features of the host response to vaccination and the underlying gene signature of vaccine protection we assessed the transcriptional responses of protected and non-protected RMs following vaccination prior to challenge.
Two groups of 15 RMs were administered 68-1 RhCMV/SIV vaccine via oral or subcutaneous delivery. Following vaccination, RMs were subjected to repeated limiting dose intrarectal SIVmac239 challenge until infected as detected as plasma virus or the de novo development of SIV Vif-specific T cell response. During the vaccination phase, blood samples were collected at time points near prime, boost, and before challenge. mRNA-seq was performed followed by bioinformatics analysis including differential gene expression, co-expression clustering, and functional enrichment analyses.
In the subcutaneous and orally-vaccinated groups, 53% and 60% of RMs cleared SIV infection after virus challenge, respectively. Protected RMs showed both an acute and sustained increase in gene expression indicative of myeloid cell responses, including genes and gene networks involved in Toll-like receptor signaling, inflammasome induction, and monocyte activation. We identified a noncanonical T-cell signaling signature in protected animals that was characterized by a decrease in of Zap70 and Tbx21 with concomitant increase in Ido1 expression. Importantly, we identified an interleukin (IL)-15/STAT5 signaling module that links with immune cell trafficking and protection from SIV infection. A rule-based machine learning analysis confirmed that gene expression signatures controlling TLR activation of macrophages and myeloid cell activation, could predict vaccine protection. Assessment of an independent cohort of naive RM treated with IL-15 revealed gene networks of the IL-15 response. Integration analyses were conducted to identify a subset of IL-15 response genes in vaccinated animals whose induced expression tracks with vaccine protection. This gene expression signature was maintained post-virus challenge.
Our results define noncanonical T cell activation, inflammatory signaling, myeloid cell activation, and IL-15 response as features of RhCMV-SIV vaccine protection.